Tardive dyskinesia (TD) is a side effect of antipsychotic or neuroleptic medications that causes involuntary movements of the face, neck, arms, and legs. These movements can affect social life, ...
Educating yourself about tardive dyskinesia helps you better understand how involuntary movements may affect your loved one’s daily functioning, emotional well-being, and participation in social ...
Tardive dyskinesia is a common side effect caused by antipsychotic use. It is a neurological disorder characterized by involuntary, repetitive movements, often involving the face, mouth, tongue, and ...
Treatment for tardive dyskinesia (TD), a condition affecting the nervous system that causes uncontrollable body movements which can be triggered by antipsychotics or other medications that affect the ...
Credit: Getty Images This patient fact sheet describes the medications that are known to induce tardive dyskinesia, its symptoms, and ways in which the disease state may be managed. Our easy-to-read ...
Tardive dyskinesia (TD) has a considerable impact on physical, psychological, social, and professional lives, according to a study published in the May/June issue of the Journal of Clinical Psychiatry ...
Antipsychotic treatment can cause involuntary movements such as lip smacking, tongue protrusions and excessive eye blinking. These movements typically occur after more than 3 months of treatment and ...
The findings of this study align with prior research that suggests lower effective doses of clozapine are required for patients of Indian descent compared to Western populations. Switching patients of ...
When you’re on certain mental health medications, you have a chance of developing this disorder. Find out which symptoms to watch for and what else can increase your risk. If you take a neuroleptic ...
Whether someone you know already has tardive dyskinesia (TD) or they're at risk for it because of a medicine they take, you might wonder how you can help. People who have this movement disorder need a ...
(RTTNews) - Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (TEVA), announced results from a study of treatment patterns among patients with tardive dyskinesia (TD) ...